ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 143 filers reported holding ASCENDIS PHARMA A/S in Q1 2019. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,998,000 | -22.7% | 15,500 | 0.0% | 0.02% | -30.0% |
| Q4 2020 | $2,585,000 | +8.1% | 15,500 | 0.0% | 0.03% | -9.1% |
| Q3 2020 | $2,392,000 | +21.6% | 15,500 | +16.5% | 0.03% | +17.9% |
| Q2 2020 | $1,967,000 | +46.8% | 13,300 | +11.8% | 0.03% | +7.7% |
| Q1 2020 | $1,340,000 | +2.3% | 11,900 | -12.5% | 0.03% | +8.3% |
| Q3 2019 | $1,310,000 | -37.5% | 13,600 | -25.3% | 0.02% | -33.3% |
| Q2 2019 | $2,096,000 | -2.1% | 18,200 | 0.0% | 0.04% | -69.5% |
| Q1 2019 | $2,142,000 | – | 18,200 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |